1. Home
  2. TARS vs CDLR Comparison

TARS vs CDLR Comparison

Compare TARS & CDLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TARS
  • CDLR
  • Stock Information
  • Founded
  • TARS 2016
  • CDLR 2008
  • Country
  • TARS United States
  • CDLR Denmark
  • Employees
  • TARS N/A
  • CDLR N/A
  • Industry
  • TARS Medicinal Chemicals and Botanical Products
  • CDLR
  • Sector
  • TARS Health Care
  • CDLR
  • Exchange
  • TARS Nasdaq
  • CDLR Nasdaq
  • Market Cap
  • TARS 1.7B
  • CDLR 1.9B
  • IPO Year
  • TARS 2020
  • CDLR N/A
  • Fundamental
  • Price
  • TARS $51.69
  • CDLR $21.17
  • Analyst Decision
  • TARS Strong Buy
  • CDLR
  • Analyst Count
  • TARS 7
  • CDLR 0
  • Target Price
  • TARS $67.14
  • CDLR N/A
  • AVG Volume (30 Days)
  • TARS 679.4K
  • CDLR 43.6K
  • Earning Date
  • TARS 11-12-2025
  • CDLR 08-26-2025
  • Dividend Yield
  • TARS N/A
  • CDLR N/A
  • EPS Growth
  • TARS N/A
  • CDLR N/A
  • EPS
  • TARS N/A
  • CDLR 0.78
  • Revenue
  • TARS $295,521,000.00
  • CDLR $546,159,718.00
  • Revenue This Year
  • TARS $33,170.29
  • CDLR $116.02
  • Revenue Next Year
  • TARS N/A
  • CDLR $80.90
  • P/E Ratio
  • TARS N/A
  • CDLR $6.75
  • Revenue Growth
  • TARS 254.45
  • CDLR 277.89
  • 52 Week Low
  • TARS $30.23
  • CDLR $17.37
  • 52 Week High
  • TARS $59.76
  • CDLR $28.75
  • Technical
  • Relative Strength Index (RSI)
  • TARS 46.25
  • CDLR 51.01
  • Support Level
  • TARS $48.20
  • CDLR $20.84
  • Resistance Level
  • TARS $59.76
  • CDLR $21.70
  • Average True Range (ATR)
  • TARS 2.04
  • CDLR 0.32
  • MACD
  • TARS -1.29
  • CDLR -0.00
  • Stochastic Oscillator
  • TARS 30.19
  • CDLR 67.48

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

About CDLR Cadeler AS

Cadeler AS is an offshore wind farm vessel contractor. It is engaged in offshore wind farm construction, maintenance, and decommissioning and provides marine and engineering operations to the wind industry, focusing on safety and the environment. The company operates six offshore jack-up wind farm installation vessels. In addition to wind farm installation, these vessels can perform maintenance, construction, decommissioning, and other tasks within the offshore industry.

Share on Social Networks: